Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00312520Phase 3Completed
Phase 3, randomised, single-blind trial of methylprednisolone in hemangioma (2 arms), sponsored by SickKids. Primary endpoint: Percent improvement in the appearance of hemangioma. Started Jul 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00312520.